Is Keto the Cure for Type II Diabetes?

A drug-free approach might be the best treatment we have for America’s most ubiquitous lifestyle disease.

Source: Is Keto the Cure for Type II Diabetes?

Reply Letter to the Editor “Metabolic Surgery Ameliorates Cardiovascular Risk in Obese Diabetic Patients: Influence of Different Surgical Procedures” December 7, 2018

We thank the authors for their interest and comments on our article “Metabolic Surgery Ameliorates Cardiovascular Risk in Obese Diabetic Patients: Influence of Different Surgical Procedures” [1]. Owing to the increasing of obesity epidemic, type 2 diabetes mellitus (T2D) is becoming a major health issue, in both developed and developing countries. It is estimated that […]

Jih-Hua Wei, Wei-Jei Lee, Shing-Jong Lin, Po-Hsun Huang

Does the RYGB Common Limb Length influence Hypertension Remission and CardioMetabolic Risk Factors? Data from the GATEWAY TRIAL. December 7, 2018

Laparoscopic Roux-En-Y Gastric Bypass (RYGB) is a standardised metabolic and bariatric procedure that results in significant weight loss and cardiometabolic risk factors improvement. However, there is no consensus on how these results may be influenced by limbs length.

Marco Nunziante, Farouk Dargai, Radwan Kassir

How Safe is Bariatric Surgery in Patients with Class I obesity (Body mass index 30-35 kg/m2)? December 7, 2018

Bariatric surgery is known to have positive effects on various aspects of metabolic syndrome and weight-related comorbidities [1–6]. The current body mass index (BMI) recommendation cutoff of 35kg/m2 for bariatric surgery was established in 1991 by the National Institutes of Health consensus guidelines [7]. Meanwhile, incidence of obesity and its associated chronic illnesses, such as […]

Xiaoxi Feng, Amin Andalib, Stacy A. Brethauer, Philip R. Schauer, Ali Aminian

Clinical Safety and Effectiveness of a Swallowable Gas-filled Intragastric Balloon System for Weight Loss: Consecutively Treated Patients in the Initial Year of US Commercialization December 7, 2018

Recently, endoscopic bariatric therapies, including intragastric balloons, have emerged as treatment options with the potential to fill the unmet need of patients who have obesity, but are currently undertreated [1]. Intragastric balloons have less weight loss than bariatric surgery but are approved by the Food and Drug Administration (FDA) for use in lower Body Mass […]

Rachel L. Moore, Michael V. Seger, Shawn M. Garber, Adam B. Smith, Richard T. Nguyen, Moses K. Shieh, Robert G. Snow, Shelby Sullivan

Endometrial Cancer and Bariatric Surgery: A Scoping Review December 7, 2018

Endometrial cancer is the most common gynecologic malignancy in developed countries, and the fourth most common cause of cancer in women [1]. In 2012, there were an estimated 319 600 new cases of uterine cancer worldwide [2]. Women in developed countries have a 2.8% lifetime risk of developing uterine cancer, most common being Type 1, […]

Christa Aubrey, Kristin Black, Sandy Campbell, Sophia Pin

Is Keto the Cure for Type II Diabetes?

Related

Leave a Reply Cancel reply

Share this:

Related

Leave a Reply Cancel reply